亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都化工有限公司銷售部  

過氧化脲,三乙基硼氫化鋰,米格列醇,他克莫司,奧利司他,阿尼西坦,七氟烷,異氟烷

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:蘇珊
  • 電話:0531-88873476
  • 郵件:13969173319@163.com
  • 傳真:0531-88873470
  • QQ:1966745892
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 利伐沙班
利伐沙班
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
型號 366789-02-8
過期 長期有效
更新 2013-07-03 17:46
 
詳細信息
利伐沙班 366789-02-8
中文別名: 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代嗎啉-4-基)苯基)-1,3-惡唑啉-5-基)甲基)噻吩-2-甲酰胺
CAS登錄號:366789-02-8
英文名稱:Rivaroxaban
分子式:C19H18CLN3O5S
分子量:435.88

過氧化尿素,過氧化脲,醋酸洗必泰,禁發 鹽酸萬古霉素,禁發 鹽酸阿比朵爾,醋酸氯己定,過碳酰胺,三水禁發此化學品 禁發,禁發此化學品 禁發,六氟異丙醇,他克莫司,雷洛昔芬,奧利司他,米格列醇,氯磷酸二乙酯,25952-53-8,禁發 鹽酸阿霉素,1404-93-9,他扎羅汀,5470-70-2,6-甲基煙酸甲酯 ,15894-70-9,普拉格雷,禁發 鹽酸氯己定,禁發 鹽酸洗必泰,15894-70-9,204205-33-4,115473-15-9,酮咯酸氨丁三醇,枸櫞酸莫沙必利,多尼培南側鏈,吉莫斯特,羥丙哌嗪,奧扎格雷,吉非替尼,索拉菲尼,舒尼替尼
©2025 濟南偉都化工有限公司銷售部 版權所有   技術支持:化工網   訪問量:20000  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |